Product category:
Antibodies
News Release from: Cambridge BioScience | Subject: HBT antibodies
Edited by the Laboratorytalk Editorial
Team on 03 November 2004
Scavenger receptor antibodies now
available
Studied primarily for their ability to bind and internalise modified lipoproteins and have been implicated in the development of atherosclerosis and other macrophage-associated functions
Cambridge BioScience offers the latest Hycult Biotechnology (HBT) novel antibodies for scavenger receptor research One of the highlights of the range is the unique antibody to lectin-like oxidised LDL-receptor-1
This is believed to be the first commercial antibody to LOX-1.
Scavenger receptors have been studied primarily for their ability to bind and internalise modified lipoproteins and have been implicated in the development of atherosclerosis and other macrophage-associated functions.
They also function as pattern recognition receptors for a wide variety of pathogens indicating a potential role in host defence.
• Cambridge BioScience: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
